Relafen 750, the unique formulation of naproxen, presents the intriguing case from a biochemical pharmacy standpoint. This mechanism of action, essentially involving suppression of cyclooxygenase enzymes – COX-1 and COX-2 – results to the reduction in prostaglandin creation. From a biochemical lens, it drug's potency is closely associated to it